ARTICLE | Financial News
Russian newco Eleventa debuts with Maxwell investment
October 5, 2012 1:00 AM UTC
Maxwell Biotech Venture Fund said it made an undisclosed investment in Russian newco Eleventa. Eleventa is partnered with Oxagen Ltd. (Abingdon, U.K.) to develop asthma therapy OC459, a prostaglandin ...